Scott Patterson

Scott Patterson is the Vice President of Biomarker Sciences at Gilead Sciences, with extensive experience in leading biomarker programs across various companies in the biomedical field. Scott has a background in research and leadership roles, with a Ph.D. in Physiology & Pharmacology from The University of Queensland. Throughout their career, Scott has held key positions in companies such as Amgen, Celera Corporation, and Farmal Biomedicines, demonstrating their expertise in biomarker strategies and diagnostic implementations.